These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33852363)

  • 1. Beyond the
    Mango VL; Heller SL
    AJR Am J Roentgenol; 2021 Sep; 217(3):770. PubMed ID: 33852363
    [No Abstract]   [Full Text] [Related]  

  • 2. Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms.
    Destounis S; Santacroce A
    AJR Am J Roentgenol; 2018 Feb; 210(2):279-284. PubMed ID: 29064754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the
    Dontchos BN; Wang GX
    AJR Am J Roentgenol; 2022 Jul; 219(1):168. PubMed ID: 35442712
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening mammography in women less than age 50 years.
    Kerlikowske K
    Curr Opin Obstet Gynecol; 2012 Feb; 24(1):38-43. PubMed ID: 22037165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the
    Destounis S
    AJR Am J Roentgenol; 2022 Sep; 219(3):525. PubMed ID: 35576520
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial.
    Carles M; Martínez-Alonso M; Pons A; Pérez-Lacasta MJ; Perestelo-Pérez L; Sala M; Vidal C; Garcia M; Toledo-Chávarri A; Codern N; Feijoo-Cid M; Romero A; Pla R; Soler-González J; Castells X; Rué M;
    Trials; 2017 Sep; 18(1):426. PubMed ID: 28899412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening mammography for average-risk women.
    Kaunitz AM; Pinkerton JV; Ghate SV; Wolf AMD
    Menopause; 2018 Mar; 25(3):343-345. PubMed ID: 29257034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Screening Benefits: Research and Controversies.
    Odle TG
    Radiol Technol; 2016 May; 87(5):529M-46M. PubMed ID: 27146193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
    Sicsic J; Pelletier-Fleury N; Moumjid N
    Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits and harms of mammography screening: understanding the trade-offs.
    Woloshin S; Schwartz LM
    JAMA; 2010 Jan; 303(2):164-5. PubMed ID: 20068211
    [No Abstract]   [Full Text] [Related]  

  • 15. [Eliciting women’s preferences for breast cancer screening].
    Sicsic J; Pelletier-Fleury N; Carretier J; Moumjid N
    Sante Publique; 2019; S2(HS2):7-17. PubMed ID: 32372583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the
    Lowry KP; Sippo DA
    AJR Am J Roentgenol; 2021 Jul; 217(1):258. PubMed ID: 33236648
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
    Bell RJ
    Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.
    Pérez-Lacasta MJ; Martínez-Alonso M; Garcia M; Sala M; Perestelo-Pérez L; Vidal C; Codern-Bové N; Feijoo-Cid M; Toledo-Chávarri A; Cardona À; Pons A; Carles-Lavila M; Rue M;
    PLoS One; 2019; 14(3):e0214057. PubMed ID: 30913217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
    Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
    Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.